English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Nucleotide based covalent inhibitors of KRas can only be efficient in vivo if they bind reversibly with GTP-like affinity

MPS-Authors
/persons/resource/persons118073

Müller,  Matthias
Abt. III: Strukturbiochemie, Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons242303

Jeganathan,  Sadasivam
Abt. III: Strukturbiochemie, Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons198400

Heidrich,  Angelika
Abt. III: Strukturbiochemie, Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons198346

Campos,  Jeremy
Abt. III: Strukturbiochemie, Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons98693

Goody,  Roger S.
Abt. III: Strukturbiochemie, Max Planck Institute of Molecular Physiology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Müller, M., Jeganathan, S., Heidrich, A., Campos, J., & Goody, R. S. (2017). Nucleotide based covalent inhibitors of KRas can only be efficient in vivo if they bind reversibly with GTP-like affinity. Scientific Reports, 7: 3687, pp. 1-11. doi:10.1038/s41598-017-03973-6.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-75C8-9
Abstract
There is no abstract available